Best in Biotech 14 Dec 2023 Seven companies shaping the future of precision medicine …The company has a few preclinical candidates that aim to address neurodegenerative diseases as well. These comprise diagnostic biomarkers, biologic drug candidates and small molecules. Alto Neuroscience California-based precision medicine… December 14, 2023 - 9 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
News and Trends 29 Nov 2017 One Mouse with All-Human Antibodies …a small fraction of this antibody diversity. Then, in 2010, a group of scientists started working on a mouse line that could produce any human antibody in the human antibody… November 29, 2017 - 6 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 3 Oct 2022 Roche launches next-generation SARS-CoV-2 Rapid Antibody Test Roche has launched the SARS-CoV-2 Rapid Antibody Test 2.0 in markets accepting the CE Mark. The test is the next generation of Roche’s existing SARS-CoV-2 Rapid Antibody Test, which launched… October 3, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
2024 biotech funding tracker: recent highlights …molecules Antiverse (United Kingdom): £3.5 million ($4.6 million) seed | AI antibody design platform Ikarovec (United Kingdom): £5 million seed | gene therapy | preclinical in geographic atrophy Archon Biosciences… February 23, 2024 - 1 minutemin - By Aurore Michelin Share WhatsApp Twitter Linkedin Email
Best in Biotech 24 Apr 2025 21 UK biotech companies you should know about …of drug discovery, with its lead candidate being SYX-5219. The company announced last month that it had initiated a phase 1 trial of the candidate for the treatment of atopic… April 24, 2025 - 27 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 2 Nov 2016 Antibody Therapies are here to Revolutionize Dermatology …preclinical stage using its Ylanthia antibody library to match drug candidates to targets provided by Leo Pharma, which will be responsible for clinical development and commercialization. However, MorphoSys will be… November 2, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 8 Oct 2025 Top biotech deals in September 2025 …company Genmab’s $8 billion acquisition of Netherlands-based Merus. The latter, being a bispecific antibody developer itself, adds to Genmab’s antibody pipeline. This includes Merus’ lead asset petosemtamab for head and… October 8, 2025 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 29 Jul 2025 10 biotech companies leading the way in Denmark …not on healthy tissues. According to Adcendo, which licensed the drug from Multitude Therapeutics in 2024, the candidate’s unique antibody design minimizes the impact on the coagulation pathway, while the… July 29, 2025 - 16 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 10 Sep 2018 10 Biotech Companies in Berlin You Should Know …biological drugs that are glycosylated with the aim to increase the efficacy and reduce the side effects of the drugs. Glycotope’s lead antibody candidate is being tested in Phase II… September 10, 2018 - 6 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 3 Nov 2022 Positive results of cancer treatment to be presented at Boston conference …in Boston. Alderaan Biotechnology is a preclinical biotech company that focuses on monoclonal antibody development. It will be making announcements about the most recent development of its new antibody candidate,… November 3, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
Best in Biotech 19 Mar 2024 The 9 hottest private biotech companies in San Diego …four clinical candidates designed to target cancer cells and one clinical candidate aimed at tackling autoimmune diseases. Its lead candidate is an NK cell therapy called FT576 intended for the… March 19, 2024 - 11 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 27 Mar 2025 12 AI drug discovery companies you should know about …targets backed by experimental validation. Anima currently has 20 preclinical candidates being evaluated for immunology, oncology, and neuroscience indications, with its most advanced candidate indicated for the treatment of lung… March 27, 2025 - 19 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email